First Major Trial Win for Contemporary DOACs in Lower-Risk Afib
Emerging randomized data favored oral anticoagulation for lower-risk patients with atrial fibrillation (Afib), researchers found. Among patients with Afib and one thromboembolic risk factor in the SINGLE-AF trial, direct oral…
